tiprankstipranks
Trending News
More News >
CorVel Corporation (CRVL)
NASDAQ:CRVL
US Market

CorVel (CRVL) Earnings Dates, Call Summary & Reports

Compare
182 Followers

Earnings Data

Report Date
May 21, 2026
TBA (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
Last Year’s EPS
0.51
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2026
Earnings Call Date:Feb 03, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a predominately positive operational and financial picture: solid year-to-date revenue (+7%) and EPS growth (+16%), improved cash generation, meaningful share repurchases, progress on a technology acquisition, and accelerating AI-driven efficiency gains. Offsetting this were modest quarter results relative to expectations, a normalized (higher) effective tax rate that dampened near-term EPS, small margin expansion, and industry headwinds from rising claim severity and medical inflation. On balance, the highlights (growth, cash strength, strategic investments, AI traction, and a debt-free balance sheet) outweigh the lowlights, which are largely manageable short-term factors and industry trends.
Company Guidance
Management guided that technology—particularly AI—and a June technology acquisition will drive meaningful cost efficiencies, margin expansion, and scalable growth in 2026, with productivity gains and realized ROI expected to more than offset pricing pressure; supporting metrics cited on the call include nine‑month revenue of $710M (up 7% y/y), fiscal YTD EPS $1.53 (up 16%), December-quarter revenue $236M (up 3%) and quarter EPS $0.47 (up 2%), net revenue retention of 100% and a 44% close rate on new business. They also pointed to operational improvements (G&A allocation down to 9.6% from 9.7%, margin tick from 23.2% to 23.3%, operating income $24.1M vs $23.8M), working capital and liquidity metrics (DSO 39 days, improved 3 days; quarter‑end cash $230M; fiscal YTD free cash flow $90M with $36M CapEx vs $24–$27M prior year), and continued capital return (185,559 shares repurchased this quarter for $13.4M; 114.9M shares repurchased to date for $868M at an average $7.55, ~69% of outstanding), all of which management presented as underpinning their forward outlook.
Fiscal YTD Revenue Growth
Revenue for the nine months ending 12/31/2025 was $710 million, a 7% increase from $664 million for the same period in the prior fiscal year.
Strong Fiscal YTD Earnings Per Share
Fiscal year-to-date earnings per share were $1.53, up 16% from $1.32 in the prior-year nine-month period.
Quarterly Revenue and EPS Expansion
December quarter revenue was $236 million, a 3% increase vs. $228 million a year earlier; quarterly EPS was $0.47, up 2% from $0.46 (adjusted for December 2024 3-for-1 stock split).
Net Revenue Retention and New Business
Net revenue retention was 100% and the company achieved a 44% close rate on new business opportunities, with reported incremental growth from existing partners.
Cash Generation and Liquidity Position
Quarter-ending cash balance was $230 million and fiscal year-to-date free cash flow was $90 million; days sales outstanding improved to 39 days (3 days better YoY).
Share Repurchase Program
Repurchased 185,559 shares for $13.4 million in the quarter; cumulatively repurchased 114.9 million shares for $868 million (representing ~69% of shares outstanding at an average price of $7.55).
Investment in Technology and CapEx for Growth
CapEx increased to $36 million YTD (from $24–27 million prior year) reflecting higher spending on proprietary software development and licenses to support scaling and product roadmap.
Acquisition and CERES Momentum
Closed a technology-centric acquisition in June; integration is ahead of plan and yielding meaningful efficiency gains in health payment integrity (CERES), driving increased market interest from large players.
AI and Automation Adoption
Expanded AI initiatives across claim prioritization, adjuster decision support, case management automation, and accelerated software development—expected to reduce service delivery costs, improve outcomes, and support margin expansion.
Debt-Free Balance Sheet
Company reiterated a strong, debt-free balance sheet positioning CorVel for strategic product expansion, technological advancement, and future acquisitions.

CorVel (CRVL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CRVL Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 21, 2026
2026 (Q4)
- / -
0.508
Feb 03, 2026
2026 (Q3)
- / 0.47
0.4572.63% (+0.01)
Nov 04, 2025
2026 (Q2)
- / 0.54
0.4520.00% (+0.09)
Aug 05, 2025
2026 (Q1)
- / 0.53
0.41526.51% (+0.11)
May 22, 2025
2025 (Q4)
- / 0.51
0.37435.83% (+0.13)
Feb 04, 2025
2025 (Q3)
- / 0.46
0.32938.91% (+0.13)
Nov 05, 2024
2025 (Q2)
- / 0.45
0.38217.80% (+0.07)
Jul 30, 2024
2025 (Q1)
- / 0.41
0.389.21% (+0.03)
May 22, 2024
2024 (Q4)
- / 0.37
0.3487.47% (+0.03)
Jan 30, 2024
2024 (Q3)
- / 0.33
0.3212.49% (<+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CRVL Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 03, 2026
$69.75$51.58-26.05%
Nov 04, 2025
$73.12$76.06+4.02%
Aug 05, 2025
$86.52$87.64+1.29%
May 22, 2025
$112.30$114.59+2.04%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does CorVel Corporation (CRVL) report earnings?
CorVel Corporation (CRVL) is schdueled to report earning on May 21, 2026, TBA (Confirmed).
    What is CorVel Corporation (CRVL) earnings time?
    CorVel Corporation (CRVL) earnings time is at May 21, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CRVL EPS forecast?
          Currently, no data Available